Kumar Neil

EDGAR CIK 0001742485

Bridgebio Pharma, Inc. - BBIO

CEO Director
Chief Executive Officer
Direct Buys
0
$0
0 Shares
Direct Sells
1
($613,826)
-27,389 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
9
($33.04) M
-905,000 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
07/02/2025
10b5-1
07/03/2025
Sell
-20,000 @ $42.73
($854,536) 4,758,447 (-0.42%) Indirect - By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
07/02/2025
10b5-1
07/03/2025
Sell
-20,000 @ $42.73
($854,514) 955,686 (-2.05%) Indirect - By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
07/01/2025
10b5-1
07/03/2025
Sell
-20,000 @ $42.53
($850,680) 4,778,447 (-0.42%) Indirect - By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
07/01/2025
10b5-1
07/03/2025
Sell
-20,000 @ $42.54
($850,720) 975,686 (-2.01%) Indirect - By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
04/22/2025
10b5-1
04/24/2025
Sell
-75,000 @ $34.11
($2,558,025) 4,873,447 (-1.52%) Indirect - By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
03/25/2025
10b5-1
03/27/2025
Sell
-75,000 @ $36.87
($2,764,943) 4,948,447 (-1.49%) Indirect - By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
02/25/2025
10b5-1
02/27/2025
Sell
-75,000 @ $33.57
($2,517,971) 5,023,447 (-1.47%) Indirect - By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
01/29/2025
10b5-1
01/30/2025
Sell
-273,068 @ $36.35
($9,925,269) 5,098,447 (-5.08%) Indirect - By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
01/28/2025
10b5-1
01/30/2025
Sell
-326,932 @ $36.29
($11,863,381) 5,371,515 (-5.74%) Indirect - By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
11/19/2024
10b5-1
11/20/2024
Sell
-27,389 @ $22.41
($613,826) 4,897,443 (-0.56%) Direct